Haoxi Health Technology Ltd.

13F holders, Q2 2025 (June 30)
3holders −3
1new positions
4sold out
1famous investor
$1.28avg. 13F price*

At the end of Q2 2025, 3 institutions reported holding Haoxi Health Technology Ltd. in their 13F filings, down 3 from Q1 2025. 1 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($19K), UBS Group AG ($6K) and Bank of America Corp. ($5). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Haoxi Health Technology Ltd.
CUSIP
G4290F118
Latest filing quarter
Q1 2026

History

Number of 13F holders

0246 Q1 2025: 6Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 5Q4 2025Q1 2026: 2Q1 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions1$19K
Exits4$130K

All 13F filers, Q1 2025 → Q2 2025: 14,706 shares bought and 117,076 shares sold, net −102,370 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

Citadel Advisors 0.00% New 14,706 $19K
UBS Group AG 0.00% Reduce -76.0% 4,539 $6K
Bank of America Corp. 0.00% No change 4 $5

"% of holder's portfolio" is HAOXI HEALTH TECHNOLOGY LTD's weight in each manager's 13F, not the share of Haoxi Health Technology Ltd. the manager owns.